Oxaprotiline: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== Oxaprotiline == | |||
[[File:Oxaprotiline.svg|thumb|right|Chemical structure of Oxaprotiline]] | |||
'''Oxaprotiline''' is a [[tetracyclic antidepressant]] (TeCA) that was developed in the 1970s. It is known for its unique chemical structure and pharmacological profile, which distinguishes it from other antidepressants such as [[tricyclic antidepressants]] (TCAs) and [[selective serotonin reuptake inhibitors]] (SSRIs). | |||
Oxaprotiline is | |||
== | == Pharmacology == | ||
== | Oxaprotiline functions primarily as a [[norepinephrine reuptake inhibitor]] (NRI), which increases the concentration of [[norepinephrine]] in the [[synaptic cleft]] and enhances adrenergic neurotransmission. Unlike many other antidepressants, it has minimal effects on [[serotonin]] reuptake, which contributes to its distinct side effect profile. | ||
=== Mechanism of Action === | |||
The primary mechanism of action of oxaprotiline involves the inhibition of the norepinephrine transporter (NET), leading to increased levels of norepinephrine in the brain. This action is believed to contribute to its antidepressant effects by enhancing mood and alertness. | |||
== Clinical Use == | |||
Oxaprotiline was investigated for the treatment of [[major depressive disorder]] (MDD) and other mood disorders. However, it was never widely marketed or approved for clinical use in many countries. Its development was overshadowed by the introduction of newer antidepressants with more favorable side effect profiles. | |||
== Side Effects == | |||
Common side effects associated with oxaprotiline include [[dry mouth]], [[constipation]], and [[dizziness]]. Due to its adrenergic activity, it may also cause [[tachycardia]] and [[hypertension]] in some patients. Unlike TCAs, it has a lower risk of causing [[sedation]] and [[weight gain]]. | |||
== Chemical Structure == | |||
Oxaprotiline is characterized by its tetracyclic structure, which includes a unique arrangement of carbon and nitrogen atoms. This structure is responsible for its pharmacological properties and distinguishes it from other classes of antidepressants. | |||
== | == Related Pages == | ||
[[ | * [[Antidepressant]] | ||
[[ | * [[Norepinephrine reuptake inhibitor]] | ||
[[ | * [[Tetracyclic antidepressant]] | ||
[[ | * [[Major depressive disorder]] | ||
[[Category:Antidepressants]] | |||
[[Category:Tetracyclic antidepressants]] | |||
Latest revision as of 10:40, 15 February 2025
Oxaprotiline[edit]
Oxaprotiline is a tetracyclic antidepressant (TeCA) that was developed in the 1970s. It is known for its unique chemical structure and pharmacological profile, which distinguishes it from other antidepressants such as tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs).
Pharmacology[edit]
Oxaprotiline functions primarily as a norepinephrine reuptake inhibitor (NRI), which increases the concentration of norepinephrine in the synaptic cleft and enhances adrenergic neurotransmission. Unlike many other antidepressants, it has minimal effects on serotonin reuptake, which contributes to its distinct side effect profile.
Mechanism of Action[edit]
The primary mechanism of action of oxaprotiline involves the inhibition of the norepinephrine transporter (NET), leading to increased levels of norepinephrine in the brain. This action is believed to contribute to its antidepressant effects by enhancing mood and alertness.
Clinical Use[edit]
Oxaprotiline was investigated for the treatment of major depressive disorder (MDD) and other mood disorders. However, it was never widely marketed or approved for clinical use in many countries. Its development was overshadowed by the introduction of newer antidepressants with more favorable side effect profiles.
Side Effects[edit]
Common side effects associated with oxaprotiline include dry mouth, constipation, and dizziness. Due to its adrenergic activity, it may also cause tachycardia and hypertension in some patients. Unlike TCAs, it has a lower risk of causing sedation and weight gain.
Chemical Structure[edit]
Oxaprotiline is characterized by its tetracyclic structure, which includes a unique arrangement of carbon and nitrogen atoms. This structure is responsible for its pharmacological properties and distinguishes it from other classes of antidepressants.
